Tirzepatide Clinic

Medications offered

As listed on the provider’s own site. Whether a product is FDA-approved or compounded is the single most important distinction here — we explain why.

• Zepbound (tirzepatide)FDA-approved
• SemaglutideType not stated
• RetatrutideType not stated

What they publish

Tirzepatide Clinic publishes 0 of 12 standard terms. Fields marked “not publicly disclosed” were not stated on the pages we captured, and we have not filled those gaps with assumptions. Compare disclosure across providers

Membership / programme fee

Pricing was not published on the page we captured

Medication cost

Not publicly disclosed on the pages we captured.

Introductory offer

Not publicly disclosed on the pages we captured.

Insurance

Not publicly disclosed on the pages we captured.

HSA / FSA

Not publicly disclosed on the pages we captured.

Consultation process

Not publicly disclosed on the pages we captured.

Eligibility

Not publicly disclosed on the pages we captured.

Lab work

Not publicly disclosed on the pages we captured.

Pharmacy fulfilment

Not publicly disclosed on the pages we captured.

Shipping

Not publicly disclosed on the pages we captured.

Support services

Not publicly disclosed on the pages we captured.

Cancellation

Not publicly disclosed on the pages we captured.

Refunds

Not publicly disclosed on the pages we captured.

What stands out

• Advertises retatrutide. Retatrutide is an investigational drug still in clinical trials and is not FDA-approved for any indication — it is not a legally marketable treatment, and material sold under that name outside a trial has not been evaluated for safety, effectiveness or quality.
• That single fact should weigh heavily in any assessment of a provider offering it.
• No pricing or clinical process detail published on the page we captured.

Questions to ask before you pay

These are things we could not settle from published pages, or that we think are easy to misread. Get answers in writing.

• Ask directly what retatrutide they are supplying, from where, and on what legal basis — an investigational compound is not an approved medicine.
• Verify prescriber licensing independently.
• Establish pricing and clinical process before engaging.

Frequently asked